TEVA — Teva Pharmaceutical Industries Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro Cap

Annual balance sheet for Teva Pharmaceutical Industries, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	2,165	2,801	3,226	3,300	3,556
Net Total Accounts Receivable
Net Total Receivables	4,529	3,696	3,408	3,059	3,709
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	12,573	12,051	12,486	12,552	13,946
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,477	6,158	6,147	4,948	4,425
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	47,666	44,011	43,480	39,326	40,748
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11,027	11,469	12,247	12,796	13,456
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	37,388	36,207	35,973	33,953	32,838
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	10,278	7,804	7,506	5,373	7,910
Total Liabilities & Shareholders' Equity	47,666	44,011	43,479	39,326	40,748
Total Common Shares Outstanding